Company profile for Alkeus Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Alkeus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing treatments against serious and untreatable diseases of the eye. The eye is one of the most complex and precious organs of the body : open or closed, the eye is constantly at work, making it fragile and vulnerable and resulting in hundreds of ocular diseases. Building on years of groundbreaking research in ophthalmology an...
Alkeus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing treatments against serious and untreatable diseases of the eye. The eye is one of the most complex and precious organs of the body : open or closed, the eye is constantly at work, making it fragile and vulnerable and resulting in hundreds of ocular diseases. Building on years of groundbreaking research in ophthalmology and on well-understood biochemical processes, our philosophy is to find creative ways to combine this scientific knowledge to invent novel medicines and to bring them from the laboratories to the bedside.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2464 Massachusetts Ave Suite 314 Cambridge, MA 02140
Telephone
Telephone
+1 (800) 287-2755
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/09/3164331/0/en/Alkeus-Pharmaceuticals-Announces-Presentation-of-Gildeuretinol-Data-at-the-American-Academy-of-Ophthalmology-AAO-2025-Annual-Meeting-October-18-21-in-Orlando.html

GLOBENEWSWIRE
09 Oct 2025

https://www.globenewswire.com/news-release/2025/08/07/3129414/0/en/Alkeus-Pharmaceuticals-Announces-Presentation-of-Positive-Interim-TEASE-3-Study-Data-in-Early-Stage-Stargardt-Disease-Patients-Treated-with-Oral-Gildeuretinol.html

GLOBENEWSWIRE
07 Aug 2025

https://www.globenewswire.com/news-release/2025/07/23/3120213/0/en/Alkeus-Pharmaceuticals-Announces-Gildeuretinol-Data-Presentations-During-the-American-Society-of-Retina-Specialists-ASRS-43rd-Annual-Meeting-July-29-August-2.html

GLOBENEWSWIRE
23 Jul 2025

https://www.globenewswire.com/news-release/2025/05/07/3076162/0/en/Alkeus-Pharmaceuticals-Presents-Gildeuretinol-Data-During-the-Association-for-Research-in-Vision-and-Ophthalmology-ARVO-2025-Annual-Meeting-May-4-8-2025.html

GLOBENEWSWIRE
07 May 2025

https://www.globenewswire.com/news-release/2025/04/24/3067634/0/en/Alkeus-Pharmaceuticals-Announces-Presentations-of-Gildeuretinol-Data-During-the-Research-in-Vision-and-Ophthalmology-ARVO-2025-Annual-Meeting-May-4-8-2025.html

GLOBENEWSWIRE
24 Apr 2025

https://www.globenewswire.com/news-release/2025/02/25/3032019/0/en/Alkeus-Pharmaceuticals-Announces-Establishment-of-Scientific-Advisory-Board.html

GLOBENEWSWIRE
25 Feb 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty